Ankasa Regenerative Therapeutics

United States
San Diego, California, United States, 92037

Company profile

Ankasa Regenerative Therapeutics company profile

Ankasa Regenerative Therapeutics is a biopharmaceutical company developing strategies to improve tissue healing by exploiting the potential of stem cell reactivation. The company is developing proprietary formulations of a potent WNT stem cell activator with the potential to accelerate tissue healing in a broad range of degenerative conditions affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. Its proprietary approach has demonstrated superiority for bone reformation over existing standards of care in various preclinical models. Ankasa Regenerative Therapeutics was established in 2014 and is headquartered in La Jolla, California.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
92037
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$14.5M
Last funding
Series Unknown / $6M / 2020-10-13
Last equity funding
Series Unknown / $6M
Investors
3
Lead investors
1
Founders
2
Articles
5

Founders and investors

Founders

Jill HelmsSanford J. Madigan

Lead investors

Avalon Ventures

Investors

Avalon VenturesCorrelation VenturesHeraeus